Page last updated: 2024-11-05

trimethadione and Pancreatic Fistula

trimethadione has been researched along with Pancreatic Fistula in 1 studies

Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.

Pancreatic Fistula: Abnormal passage communicating with the PANCREAS.

Research Excerpts

ExcerptRelevanceReference
"To examine pancreatic excretion of dimethadione (DMO), a weak organic acid, as well as of its precursor trimethadione (TMO), TMO was given orally to dogs with pancreatic fistulae at a dose of 10-160 mg/kg/day over a period of 14 days."3.68Pancreatic excretion of dimethadione and trimethadione by repeated oral administration of trimethadione in dogs. ( Ibuki, E; Kato, H; Noda, A; Okumura, I; Tamada, M; Watanabe, T, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noda, A1
Okumura, I1
Kato, H1
Ibuki, E1
Tamada, M1
Watanabe, T1

Other Studies

1 other study available for trimethadione and Pancreatic Fistula

ArticleYear
Pancreatic excretion of dimethadione and trimethadione by repeated oral administration of trimethadione in dogs.
    Digestion, 1990, Volume: 46, Issue:1

    Topics: Administration, Oral; Animals; Dimethadione; Dogs; Dose-Response Relationship, Drug; Pancreas; Pancr

1990